Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
18.30
-0.13 (-0.71%)
At close: Jan 6, 2026, 4:00 PM EST
18.40
+0.10 (0.55%)
After-hours: Jan 6, 2026, 6:21 PM EST
Neurogene Market Cap
Neurogene has a market cap or net worth of $283.46 million as of January 6, 2026. Its market cap has decreased by -12.43% in one year.
Market Cap
283.46M
Enterprise Value
32.91M
1-Year Change
-12.43%
Ranking
Category
Stock Price
$18.30
Market Cap Chart
Since December 19, 2023, Neurogene's market cap has increased from $193.64M to $283.46M, an increase of 46.39%. That is a compound annual growth rate of 20.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 283.46M | -11.17% |
| Dec 31, 2025 | 319.09M | -6.03% |
| Dec 31, 2024 | 339.58M | 36.64% |
| Dec 29, 2023 | 248.52M | 28.34% |
| Dec 19, 2023 | 193.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.55B |
| Johnson & Johnson | 492.24B |
| AbbVie | 389.14B |
| UnitedHealth Group | 309.81B |
| AstraZeneca | 280.48B |
| Merck & Co. | 266.67B |
| Novartis AG | 262.61B |
| Novo Nordisk | 241.55B |